Patents by Inventor Timothy J. Kamerzell

Timothy J. Kamerzell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY FORMULATION
    Publication number: 20200392220
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Application
    Filed: February 21, 2020
    Publication date: December 17, 2020
    Applicant: Genentech, Inc.
    Inventors: Yatin R. GOKARN, Timothy J. KAMERZELL, Megan LI, Mary CROMWELL, Hong LIU
  • ANTIBODY FORMULATION
    Publication number: 20180171004
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Application
    Filed: July 24, 2017
    Publication date: June 21, 2018
    Inventors: Yatin R. GOKARN, Timothy J. KAMERZELL, Megan LI, Mary CROMWELL, Hong LIU
  • ANTIBODY FORMULATION
    Publication number: 20160251422
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Application
    Filed: November 25, 2015
    Publication date: September 1, 2016
    Inventors: Yatin R. GOKARN, Timothy J. KAMERZELL, Megan LI, Mary CROMWELL, Hong LIU
  • Antibody formulation
    Patent number: 9226961
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: January 5, 2016
    Assignee: Genentech, Inc.
    Inventors: Yatin R. Gokarn, Timothy J. Kamerzell, Megan Li, Mary Cromwell, Hong Liu
  • ANTIBODY FORMULATION
    Publication number: 20140099301
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 10, 2014
    Applicant: Genentech, Inc.
    Inventors: Yatin R. Gokarn, Timothy J. Kamerzell, Megan Li, Mary Cromwell, Hong Liu
  • ANTIBODY FORMULATION
    Publication number: 20110226650
    Abstract: The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
    Type: Application
    Filed: December 20, 2010
    Publication date: September 22, 2011
    Applicant: Genentech, Inc.
    Inventors: Yatin R. Gokarn, Timothy J. Kamerzell, Megan Li, Mary Cromwell, Hong Liu